X

Trial Profile

Role of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte) in Patients Wih Leptomeningeal Metastasis of Breast Cancer. A Randomized Phase III Study

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 May 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cytarabine (Primary)
Indications Meningeal carcinomatosis
Focus Therapeutic Use
Acronyms DEPOSEIN

Most Recent Events

11 Jun 2019 Status changed from active, no longer recruiting to completed.
22 Mar 2018 Planned End Date changed from 1 Jul 2017 to 1 Jan 2019.
22 Mar 2018 Planned primary completion date changed from 1 Jan 2017 to 1 Aug 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com